A look at the pandemic’s effect on supply chain, with McKesson’s Craig Dolan

Healthcare Finance News April 6, 2021
Susan Morse

McKesson was selected by the Centers for Disease Control and Prevention to be the centralized distributor for vaccines and ancillary supply kits.

A year after the COVID-19 pandemic sent the country into lockdown, there is light at the end of the tunnel with more than 15% of the U.S. population now fully vaccinated.

McKesson is playing a key role in the COVID-19 vaccine rollout, as in August 2020, the pharmaceutical distribution and IT company was selected by the Centers for Disease Control and Prevention to be the centralized distributor for vaccines and ancillary supply kits.

Under a centralized model, the U.S. government directs McKesson on all aspects of distribution, including where and when to ship vaccines and...

Today's Sponsors

Today's Sponsor